Skip to Main Content

Paper Details

Analysis of mutation status and homologous recombination deficiency in tumors of patients with germline BRCA1 or BRCA2 mutations and metastatic breast cancer: OlympiAD.
Ann Oncol
19
2021
BRCA1, BRCA1 and, BRCA1 or, BRCA1m, BRCA1m patients, BRCA2, BRCA2 mutation, BRCA2 mutations, BRCA2m, HER2, HER2-negative metastatic breast cancer, HRD, Olaparib, OlympiAD, PARP, PATIENTS, allele, blood, blood samples, gBRCAm, germline, gsLOH, homologous recombination deficiency, human, human epidermal growth factor receptor 2, metastatic breast cancer, patients, poly(ADP-ribose), poly(ADP-ribose) polymerase, tBRCAm, tumor, tumors

Datasets

Release 1.2